| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |